1127 related items for PubMed ID: 29745742
21. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
22. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A.
Pediatr Cardiol; 2013 Aug; 34(6):1476-81. PubMed ID: 23463134
[Abstract] [Full Text] [Related]
23. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Aug; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
24. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
Turk J Pediatr; 2020 Aug; 62(1):1-9. PubMed ID: 32253860
[Abstract] [Full Text] [Related]
25. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
Pediatr Cardiol; 2003 Aug; 24(2):122-6. PubMed ID: 12457252
[Abstract] [Full Text] [Related]
26. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
[Abstract] [Full Text] [Related]
27. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Matsubara D, Kosami K, Sasahara T, Belay ED.
Am Heart J; 2020 Jul 15; 225():120-128. PubMed ID: 32497905
[Abstract] [Full Text] [Related]
28. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
Eur J Pediatr; 2019 Mar 15; 178(3):315-322. PubMed ID: 30499051
[Abstract] [Full Text] [Related]
29. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
Pediatr Cardiol; 2015 Aug 15; 36(6):1166-72. PubMed ID: 25812827
[Abstract] [Full Text] [Related]
30. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 15; 14(12):938-41. PubMed ID: 23234782
[Abstract] [Full Text] [Related]
31. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
[Abstract] [Full Text] [Related]
32. Outcomes of Kawasaki Disease: A Single-Center Experience.
Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
Clin Pediatr (Phila); 2015 Jun 31; 54(6):579-84. PubMed ID: 25475592
[Abstract] [Full Text] [Related]
33. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
Zhonghua Er Ke Za Zhi; 2006 Dec 31; 44(12):891-5. PubMed ID: 17254453
[Abstract] [Full Text] [Related]
34. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
Clin Exp Med; 2022 Nov 31; 22(4):621-628. PubMed ID: 35039938
[Abstract] [Full Text] [Related]
35. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
Ruan Y, Ye B, Zhao X.
Pediatr Infect Dis J; 2013 Oct 31; 32(10):e397-402. PubMed ID: 23722531
[Abstract] [Full Text] [Related]
36. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
37. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
Clin Chim Acta; 2017 Aug 27; 471():76-80. PubMed ID: 28526535
[Abstract] [Full Text] [Related]
38. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, Ancora G, Malaigia L, Bodnar T, Di Fazzio G, Lami F, Valletta E, Cicero C, Biasucci G, Iughetti L, Marchetti F, Sogno Valin P, Amarri S, Brusa S, Sprocati M, Maggiore G, Dormi A, Lanzoni P, Donti A, Lanari M.
PLoS One; 2018 Aug 27; 13(9):e0202658. PubMed ID: 30180185
[Abstract] [Full Text] [Related]
39. Ulinastatin therapy in kawasaki disease.
Iwashima S, Seguchi M, Matubayashi T, Ohzeki T.
Clin Drug Investig; 2007 Aug 27; 27(10):691-6. PubMed ID: 17803344
[Abstract] [Full Text] [Related]
40. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
Zhonghua Er Ke Za Zhi; 2006 May 27; 44(5):324-8. PubMed ID: 16780705
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
